about
Ubiquitin ligase ARF-BP1/Mule modulates base excision repairp16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells.Phytochemicals for the Management of MelanomaMelanoma: new insights and new therapiesNUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development StrategyEpigenetic regulation in human melanoma: past and futureDiscrepant alterations in main candidate genes among multiple primary melanomasIn-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.Zebrafish have a competent p53-dependent nucleotide excision repair pathway to resolve ultraviolet B-induced DNA damage in the skin.EZH2: not EZHY (easy) to deal.Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferationUsing genetics and genomics strategies to personalize therapy for cancer: focus on melanomap16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1.Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanomaStepping up melanocytes to the challenge of UV exposure.GPR56 plays varying roles in endogenous cancer progression.Frequent p16-independent inactivation of p14ARF in human melanoma.The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet lightKinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanomaHypermethylation of the 5' CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression.Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARFGenetics of melanomaMelanoma invasion - current knowledge and future directions.Melanocyte receptors: clinical implications and therapeutic relevance.Issues affecting molecular staging in the management of patients with melanomaLoss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.Genetics of coronary artery disease: focus on genome-wide association studies.Small molecules and targeted therapies in distant metastatic disease.Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death.Genetics of uveal melanoma and cutaneous melanoma: two of a kind?Pathways of oncogene-induced senescence in human melanocytic cellsPredicting and preventing melanoma invasiveness: advances in clarifying E2F1 function.Combination of targeted therapy and immunotherapy in melanoma.Obesity and melanoma: exploring molecular links.
P2860
Q24310413-8B679D42-B90A-4431-832C-D07661549AD5Q25255634-C396662B-D3AB-40AC-96AC-C12FFC6A2E0CQ26766708-DBD927CF-E23E-4342-BA42-C7B24A80FC35Q26853127-68A5EA28-C958-464B-B4BB-03877048E90FQ27348507-FF4EEA00-38B2-481A-80EC-75B7A9CCADD9Q28076840-D5A77B71-5817-443A-858B-6738C92F6802Q28085681-F6F7AC36-88FB-4376-8E38-A74B31D57F95Q30578299-B48A5CE2-3FD8-4123-BB9A-99076EE680ABQ30936571-E602D910-2AB8-4F5A-A8E8-56A02AAC2DF0Q33584237-F0407E52-4BD3-4546-B2E1-E4AECC9F96A6Q33610902-2BF0DE34-3857-4283-8CA8-22075D6C45F4Q33647719-0019A368-111F-49E5-BE09-F093920D2441Q33913135-7E490A87-BD87-4968-BA6E-FDBE2320683CQ33965328-F3D6C10B-F3CB-4F3A-86EA-5A378ED7AAA0Q33974856-54F09624-72CF-49F7-BCF4-2A1AE8E13710Q34044908-7BC26205-2C25-43E1-AD81-2463E3E4F4E0Q34530415-717A888A-86CD-416C-BADD-775CF12DF0A9Q34616432-CA768C5B-272B-4C39-B4C3-7088D418A14EQ34731364-86F092F2-5AEE-4A21-A007-740A3E682B81Q35541602-BFA332B8-E808-42C0-A2A9-183906C25C86Q35646698-7316CC3E-DF95-4DF2-8785-8713EC62ACD7Q35706499-52CC3425-5694-4C4D-81C5-42791138FD07Q36316169-D11FAEAF-0A58-4BE5-994E-D7092F658A09Q36376592-399BA835-1823-4E49-9C3E-2CCC56D27253Q36563659-D4A26607-F76B-4154-8828-0767B282B16CQ36828214-F5A4C741-32CF-4A9F-83A5-C730B3A779A7Q36954814-5D9EEE86-60F0-4D3B-A05B-45670E9EE542Q36990701-97F54FDE-1A8E-40A8-BA94-98B124152889Q37025145-6D44558F-070E-404C-9C05-FC8DB82742E6Q37288883-BF704537-87FA-4EDB-8D58-557C7F515DD9Q37410536-14805465-05CC-4421-8521-7A8F3B75BA0EQ37418945-F2C0A875-E743-4416-A095-2222461F531CQ37555793-C41F8140-0A3A-4D94-BF4D-8D43CD95EA5DQ37665516-EBD53683-53CE-405C-BF3E-D0C8994DD646Q37710422-CBD49ADE-4410-477E-9C13-104914370BE5Q37772777-F23FAD87-1CB3-4986-A804-188293D1060AQ37777015-3C4AC39B-FEEC-45AE-9FC0-1912FCD56811Q37809859-F9146645-7912-4EDF-B57D-5F5DDE7817B3Q37918893-BED9E003-2BE6-49F5-9C16-0EF41E8FD245Q38095892-9AB4E5FC-19E8-4449-B7FF-62F333CB343B
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The INK4a/ARF locus and melanoma.
@ast
The INK4a/ARF locus and melanoma.
@en
type
label
The INK4a/ARF locus and melanoma.
@ast
The INK4a/ARF locus and melanoma.
@en
prefLabel
The INK4a/ARF locus and melanoma.
@ast
The INK4a/ARF locus and melanoma.
@en
P2860
P356
P1433
P1476
The INK4a/ARF locus and melanoma.
@en
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206461
P407
P577
2003-05-01T00:00:00Z